TerminatedPhase 4NCT00815633
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
Studying Pityriasis rubra pilaris
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Joshua Zeichner
- Principal Investigator
- Joshua Zeichner, MD, M.DIcahn School of Medicine at Mount Sinai
- Intervention
- Alefacept(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 30 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Collaborators
Astellas Pharma Inc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00815633 on ClinicalTrials.govOther trials for Pityriasis rubra pilaris
Additional recruiting or active studies for the same condition.